Balmain Launches Balmain Beauty With a New Luxury Fragrance Collection: Les Éternels
27.8.2024 09:30:00 EEST | Business Wire | Press release
Balmain announces today the launch of its first beauty creation, a collection of eight all-gender eaux de parfum, “Les Éternels de Balmain.” This trailblazing fragrance experience was inspired by Pierre Balmain’s Parisian legacy and Olivier Rousteing’s modern influence on fashion, and now beauty.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240826817417/en/
Balmain Beauty/ Les Éternels de Balmain (Photo Credit: Balmain Beauty/ Richard Pierce)
Identity Has a Fragrance
Olivier Rousteing inventively builds upon the house’s signature French heritage to share his new vision of avant-garde beauty, fueled by respect, love, and unity. Infusing resolute inclusivity to modern luxury fragrance-making, Olivier Rousteing’s creative vision galvanizes audiences and fans globally to celebrate their individual beauty. Fragrance becomes the first beauty chapter of a new book for the brand, to expand globally into new categories in the future.
“Balmain Beauty gives you the freedom to live your truth, free and powerful. Beauty is about being yourself and having the confidence to embrace who you are,” said Olivier Rousteing, Creative Director of Balmain. "Fashion cannot exist without beauty, and beauty cannot exist without fashion. Beauty is part of your silhouette, of who you are, just like the way you dress. I want to represent all the beauties of the world and welcome everyone without exceptions.”
Taking 21st-century Paris to the world, Balmain Beauty encapsulates the quest to find yourself and unite with others to change the meaning of beauty for the future.
Introducing Les Éternels de Balmain
Powered by a richly crafted duality of ingredients, Les Éternels de Balmain is inspired by the universal quest for self-realization and identity. This inaugural collection includes eight multi-layered scents from four distinctive olfactive families – Musk, Amber, Floral, and Woody.
Olivier Rousteing has been the lead architect of Balmain Beauty from inception, and in every aspect of creation from concept to scent development, to package design and campaign imagery. He studied perfumery, learning the creation process through hands-on training. After consulting Balmain’s storied archives, he handpicked four of Balmain's legacy scents to be reinvented for the modern era: Vent Vert, Ivoire, Ébène, and Carbone. Four new fragrances complete the collection: Sel d’Ambre, Rouge, Bronze, and Bleu Infini.
“Balmain Beauty is forging a new, avant-garde space in luxury beauty that celebrates the legacy and inclusive spirit of the iconic house of Balmain,” said Guillaume Jesel, who oversees Balmain Beauty as the President and CEO, TOM FORD and Luxury Business Development, The Estée Lauder Companies. “Olivier Rousteing is one of the most accomplished designers of his generation, inventing revolutionary concepts at the confluence of past, present, and future. It has been an extraordinary journey bringing his vision for Balmain Beauty to life.”
“Just like Olivier Rousteing’s most impressive runways, Balmain’s ambitious plans for future luxury growth build directly upon a skilled melding together of the richness of our singular heritage with a distinctively modern outlook,” explains Matteo Sgarbossa, Chief Executive Officer, Balmain. “Our agreement with The Estée Lauder Companies for Balmain Beauty is an obvious embodiment of that strategy. With this partnership, the house begins a new chapter, making very clear to all our commitment to maximizing cross-category possibilities as we move forward, driven by the passion of our ‘Balmain Army’ and determined to fully realize this house’s potential to become a true leader in the luxury world.”
The Olfactive Power of Duality
Les Éternels de Balmain features future-forward elements joined by precious and legendary ingredients:
Olfactive Family: Musk
- Carbone drives the quest for identity and freedom to confidently reflect all the facets of who you truly are (maximalist musk/ minimalist rose).
Olfactive Family: Amber
- Sel d'Ambre’s golden mystery illuminates the path to inner peace and self-realization (glowing amber/ salty ambergris).
Olfactive Family: Floral
- Vent Vert reinvents the iconic green fragrance for a new age, respecting nature forever in a timeless journey through past, present, and future (airy vert de mandarine/ sensual jasmine).
- Rouge radiates addictive love, reminiscent of Los Angeles’ magic hour, when the sky is not even the limit (addictive bouquet/ radiant woods).
- Ivoire carries Balmain’s New French Style legacy to the world and into the future. It unites all the beauties of the world, no exceptions (intoxicating tubéreuse de nuit/ untamed vetiver).
Olfactive Family: Woody
- Bronze symbolizes rebirth, majestically rising like the phoenix from the ashes (blazing cedarwoods/ cooling patchouli).
- Ébène is the revival of Pierre Balmain’s 1983 Africa-inspired fragrance, envisioned through the lens of Olivier Rousteing’s discovery of his origins. It ushers in the age of self-discovery and a journey to reveal our universal origin (eternal ebony wood/ precious myrrh oil).
- Bleu Infini transports to endless skies, infinite seas, and their call to set you free (warm cistus absolute/ salted lichen).
“Balmain Beauty embodies a steadfast commitment to excellence in perfumery, emphasizing not only the olfactive experience, but also the evocative emotions it elicits brought to life by an iconic visual campaign,” added Nathalie Berger Duquene, SVP, Global General Manager, Balmain Beauty, The Estée Lauder Companies. “The beauty of craftsmanship is exuded in both the packaging design and ingredients used. Our fragrances hold tension, power, and strength – they are quintessentially Balmain, rooted in diversity and inclusivity.”
The collection is inspired by Balmain’s first flacon created in 1946, a masterpiece of simplicity and timelessness. Duality was expressed in the design with contrasting elemental shapes of the circle and square, signature black and gold colors, and the label spread over two facets.
Building on this foundation, the new flacon delivers a multisensory and luxurious modern experience. The square is elongated into a lozenge; the Balmain signature rayure covering the glass echoes the gold collar’s existing texture; a new finish and color palette flatters the touch and the eye. On the cap, a graphic PB monogram symbolizes Balmain, extracted from the iconic 1970 brand labyrinth motif.
Follow the brand on social media at @BalmainBeauty and visit www.balmainbeauty.com and www.balmainbeauty.eu to shop the collection and learn more.
#BalmainBeauty
About Balmain Beauty
Balmain Beauty was established in 2022 through a partnership between the celebrated fashion house Balmain Paris and The Estée Lauder Companies to celebrate all the beauties of the world, no exceptions. It builds upon Balmain's exceptional fashion and fragrance legacy to change the meaning of beauty for the future. Its luxury beauty lines are crafted in close collaboration with Balmain Creative Director Olivier Rousteing to reflect his bold vision. By standing for the power of respect, love, and unity, Balmain Beauty embodies avant-garde luxury. In September 2024, the brand launched Les Éternels de Balmain, a new fragrance experience comprising eight all-gender eaux de parfum. Balmain Beauty is butterfly mark certified, committing to meet higher standards for people and nature.
About Balmain
More than 75 years ago, when Pierre Balmain first introduced his “New French Style,” it immediately became clear to all that his eponymous house was offering a distinctly fresh, bold, and feminine conception of haute couture, one which broke with many of the well-established conventions of the era. His audacity paid off. Pierre Balmain became one of the handful of young French talents who ushered in the mid-century golden age of couture and helped to re-establish Paris as the world’s fashion capital.
Since 2011, Balmain Creative Director Olivier Rousteing has been inventively building upon Pierre Balmain’s extraordinary legacy, while always remaining true to his own determination to design clothes that reflect the way his inclusive, powerful and global Balmain Army wishes to live today. The result is 21st-century Balmain’s renewed French style—a unique and instantly recognizable house silhouette and attitude that highlights the singular craftsmanship of the celebrated Balmain ateliers, while consistently referencing a rich Parisian heritage.
NYSE: EL
ELC-B
View source version on businesswire.com: https://www.businesswire.com/news/home/20240826817417/en/
Contacts
Media Contact Beauty
Sarah Moreau
smoreau@balmainbeauty.com
Media Contact Fashion
Marie Valot
mvalot@balmain.fr
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 17:00:00 EEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 16:34:00 EEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 12:00:00 EEST | Press release
Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely with healthcare authorities and other stakeholders to support timely access for people with Parkinson’s disease who continue to experience moderate to severe motor fluctuations despite current oral therapies. Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. Despite availab
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 11:16:00 EEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 11:00:00 EEST | Press release
Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich, the findings show that the clinically relevant reductions in low-density lipoprotein cholesterol (LDL-C) achieved within the first year of treatment are estimated to translate into clinically meaningful reductions in 10-year cardiovascular (CV) risk.1 The data further reinforce the clinical value of bempedoic acid, and its fixed-dose combination with ezetimibe, across a diverse range of patient subtypes, regardless of gender and glycaemic profile (diabetes, pre-diabetes, or normoglycemia).2,3 Key findings from the new analyses of the MILOS study include: 10-year CV risk estimate reduction: An analysis of 960 at-risk patients estimated that one year of bempedoic acid-add-on ther
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom